Position in BMY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$16,421
-$864 QoQ
Shares Held
285
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2,408
of 2,506 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Phillip James Consulting Co. holds $676,290 across 9 Drug Manufacturers - General names. BMY ranks #5 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
207 | $248,282 | |
| 2 | JNJ |
Johnson & Johnson
|
966 | $245,335 | |
| 3 | MRK |
Merck & Co., Inc.
|
792 | $101,772 | |
| 4 | ABBV |
AbbVie Inc.
|
185 | $46,553 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
285 | $16,421 | |
| 6 | PFE |
Pfizer Inc
|
581 | $13,990 | |
| 7 | AMGN |
Amgen Inc
|
5 | $1,810 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
10 | $1,263 |
All Filings in BMY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,421 | 285 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $17,285 | 285 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $14,132 | 262 | Shares | Sole | 2026-02-23 | |
| No filing history on record for this holder in this stock. | ||||||